相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical Efficacy and Nephrotoxicity of the Loading Dose Colistin for the Treatment of Carbapenem-Resistant Acinetobacter baumannii in Critically Ill Patients
Wasan Katip et al.
PHARMACEUTICS (2022)
Risk factors for carbapenem-resistant Gram-negative bacterial infections: a systematic review
Zaira R. Palacios-Baena et al.
CLINICAL MICROBIOLOGY AND INFECTION (2021)
Clinical Efficacy and Nephrotoxicity of Colistin Alone versus Colistin Plus Vancomycin in Critically Ill Patients Infected with Carbapenem-Resistant Acinetobacter baumannii: A Propensity Score-Matched Analysis
Wasan Katip et al.
PHARMACEUTICS (2021)
Trends and correlation between antibacterial consumption and carbapenem resistance in gram-negative bacteria in a tertiary hospital in China from 2012 to 2019
Chunhong Liang et al.
BMC INFECTIOUS DISEASES (2021)
Admission screening and cohort care decrease carbapenem resistant enterobacteriaceae in Vietnamese pediatric ICU's
K. Garpvall et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2021)
Evolution of Acinetobacter baumannii in Clinical Bacteremia Patients
Henan Li et al.
INFECTION AND DRUG RESISTANCE (2021)
Gram-Negative Bacteria Bloodstream Infections in Patients with Hematological Malignancies - The Impact of Pathogen Type and Patterns of Antibiotic Resistance: A Retrospective Cohort Study
Yishu Tang et al.
INFECTION AND DRUG RESISTANCE (2021)
Shift in the Dominant Sequence Type of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infection from ST11 to ST15 at a Medical Center in Northeast China, 2015-2020
Jingjing Chen et al.
INFECTION AND DRUG RESISTANCE (2021)
Inappropriate initial antimicrobial therapy for hematological malignancies patients with Gram-negative bloodstream infections
Yishu Tang et al.
INFECTION (2020)
The clinical impact of Stenotrophomonas maltophilia bacteremia on the 30-day mortality rate in patients with hematologic disorders: a single-institution experience
Haiyan Bao et al.
INFECTION (2020)
Different screening frequencies of carbapenem-resistant Enterobacteriaceae in patients undergoing hematopoietic stem cell transplantation: which one is better?
Ting-Ting Yang et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2020)
The Burden of Bloodstream Infections due to Stenotrophomonas Maltophilia in the United States: A Large, Retrospective Database Study
Bin Cai et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
Infections Due to Carbapenem-Resistant Bacteria in Patients With Hematologic Malignancies
Rym Lalaoui et al.
FRONTIERS IN MICROBIOLOGY (2020)
Predictive factors for sepsis by carbapenem resistant Gram-negative bacilli in adult critical patients in Rio de Janeiro: a case-case-control design in a prospective cohort study
Elisangela M. Lima et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2020)
A Comparison of Colistin versus Colistin Plus Meropenem for the Treatment of Carbapenem-Resistant Acinetobacter baumannii in Critically Ill Patients: A Propensity Score-Matched Analysis
Wasan Katip et al.
ANTIBIOTICS-BASEL (2020)
Risk Factors and Outcomes of Antibiotic-resistant Pseudomonas aeruginosa Bloodstream Infection in Adult Patients With Acute Leukemia
Yuanqi Zhao et al.
CLINICAL INFECTIOUS DISEASES (2020)
A Novel Algorithm to Analyze Epidemiology and Outcomes of Carbapenem Resistance Among Patients With Hospital-Acquired and Ventilator-Associated Pneumonia A Retrospective Cohort Study
Marya D. Zilberberg et al.
CHEST (2019)
Risk factors for mortality due to Acinetobacter baumannii bacteremia in patients with hematological malignancies - a retrospective study
Liat Shargian-Alon et al.
LEUKEMIA & LYMPHOMA (2019)
Epidemiology and Diagnostics of Carbapenem Resistance in Gram-negative Bacteria
Patrice Nordmann et al.
CLINICAL INFECTIOUS DISEASES (2019)
Bloodstream infections with gram-negative organisms and the impact of multidrug resistance in patients with hematological malignancies
Sebastian Scheich et al.
ANNALS OF HEMATOLOGY (2018)
The combined use of tigecycline with high-dose colistin might not be associated with higher survival in critically ill patients with bacteraemia due to carbapenem-resistant Acinetobacter baumannii
T. Amat et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
Prognostic factors and scoring model of hematological malignancies patients with bloodstream infections
Yishu Tang et al.
INFECTION (2018)
The epidemiological impact and significance of carbapenem resistance in Pseudomonas aeruginosa bloodstream infections: a matched case-case-control analysis
Tzach Aviv et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2018)
2018 WSES/SIS-E consensus conference: recommendations for the management of skin and soft-tissue infections
Massimo Sartelli et al.
WORLD JOURNAL OF EMERGENCY SURGERY (2018)
Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia
Pranita D. Tamma et al.
CLINICAL INFECTIOUS DISEASES (2017)
Screening for carbapenem-resistant Enterobacteriaceae: Who, When, and How?
Sandra S. Richter et al.
VIRULENCE (2017)
Acinetobacter baumannii bacteraemia in patients with haematological malignancy: a multicentre retrospective study from the Infection Working Party of Jiangsu Society of Hematology
X. Wang et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2017)
Clinical efficacy of ceftazidime/avibactam versus other active agents for the treatment of bacteremia due to carbapenemase-producing Enterobacteriaceae in hematologic patients
Juan J. Caston et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2017)
Update of Sepsis in the Intensive Care Unit
Kelly Roveran Genga et al.
JOURNAL OF INNATE IMMUNITY (2017)
Effects of an antimicrobial restriction system on appropriate carbapenem use in a hospital without infectious diseases consultation
Warangkhana Wanla et al.
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2017)
Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias
Alessandra Micozzi et al.
BMC INFECTIOUS DISEASES (2017)
Pseudomonas aeruginosa: breaking down barriers
Bryan J. Berube et al.
CURRENT GENETICS (2016)
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey
Enrico Maria Trecarichi et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Bloodstream infection caused by extensively drug-resistant Acinetobacter baumannii in cancer patients: high mortality associated with delayed treatment rather than with the degree of neutropenia
M. P. Freire et al.
CLINICAL MICROBIOLOGY AND INFECTION (2016)
Carbapenemase-producing Klebsiella pneumoniae bloodstream infections in neutropenic patients with haematological malignancies or aplastic anaemia: Analysis of 50 cases
Polydoros Tofas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Bacteremia due to carbapenem-resistant Enterobacteriaceae in neutropenic patients with hematologic malignancies
Michael J. Satlin et al.
JOURNAL OF INFECTION (2016)
Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: an Italian multidisciplinary consensus statement
Corrado Girmenia et al.
HAEMATOLOGICA (2015)
Mortality burden related to infection with carbapenem-resistant Gram-negative bacteria among haematological cancer patients: a retrospective cohort study
Nizar Andria et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: an Italian multidisciplinary consensus statement
Corrado Girmenia et al.
HAEMATOLOGICA (2015)
European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia
Diana Averbuch et al.
HAEMATOLOGICA (2013)
Risk factors for carbapenem-resistant Gram-negative bacteremia in intensive care unit patients
Christina Routsi et al.
INTENSIVE CARE MEDICINE (2013)
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
Alison G. Freifeld et al.
CLINICAL INFECTIOUS DISEASES (2011)
分享论文
